Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada · Delayed Price · Currency is CAD 10.24
+0.54 (5.57%)
May 25, 2026, 4:00 PM EST
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of CAD 668.95 million as of May 22, 2026. Its market cap has increased by 250.75% in one year.
Market Cap
668.95M
Enterprise Value
517.18M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10.24
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from 78.01M to 668.95M, an increase of 757.55%. That is a compound annual growth rate of 51.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 25, 2026 | 668.95M | 27.98% |
| Dec 31, 2025 | 522.69M | 225.34% |
| Dec 31, 2024 | 160.66M | 9.74% |
| Dec 29, 2023 | 146.40M | 85.76% |
| Dec 30, 2022 | 78.81M | 125.87% |
| Dec 31, 2021 | 34.89M | -55.27% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 1.14B |
| Satellos Bioscience | 204.77M |
| Helix BioPharma | 124.50M |
| Quantum BioPharma | 74.56M |
| Sharp Therapeutics | 63.16M |
| Telescope Innovations | 63.03M |
| ME Therapeutics Holdings | 60.10M |
| NurExone Biologic | 58.91M |